Variables | Adjusted OR (95% CI) | P |
---|---|---|
Serum lactate measurement | Â | Â |
 Intermediate crowding groupa | 0.91 (0.51 to 1.63) | 0.747 |
 High crowding groupa | 0.73 (0.38 to 1.41) | 0.346 |
 ED occupancy rate (+10%)b | 0.95 (0.88 to 1.03) | 0.206 |
Blood cultures before antibiotics | Â | Â |
 Intermediate crowding groupa | 1.31 (0.52 to 3.30) | 0.561 |
 High crowding groupa | 0.80 (0.30 to 2.16) | 0.659 |
 ED occupancy rate (+10%)b | 0.98 (0.86 to 1.10) | 0.711 |
Early broad-spectrum antibiotics | Â | Â |
 Intermediate crowding groupa | 0.76 (0.50 to 1.15) | 0.193 |
 High crowding groupa | 0.57 (0.35 to 0.91) | 0.019 |
 ED occupancy rate (+10%)b | 0.93 (0.88 to 0.98) | 0.018 |
Intravenous fluid challenge | Â | Â |
 Intermediate crowding groupa | 1.20 (0.60 to 2.39) | 0.603 |
 High crowding groupa | 0.86 (0.40 to 1.84) | 0.697 |
 ED occupancy rate (+10%)b | 0.99 (0.91 to 1.10) | 0.974 |
CVP ≥8 mmHg achieved |  |  |
 Intermediate crowding groupa | 1.07 (0.69 to 1.65) | 0.772 |
 High crowding groupa | 0.83 (0.50 to 1.37) | 0.462 |
 ED occupancy rate (+10%)b | 0.95 (0.89 to 1.01) | 0.095 |
MAP ≥65 mmHg achievedc |  |  |
 Intermediate crowding groupa | 0.29 (0.06 to 1.45) | 0.133 |
 High crowding groupa | 0.34 (0.07 to 1.79) | 0.203 |
 ED occupancy rate (+10%)b | 0.93 (0.80 to 1.10) | 0.442 |
Scvo2 ≥70% achieved |  |  |
 Intermediate crowding groupa | 0.83 (0.53 to 1.29) | 0.408 |
 High crowding groupa | 0.42 (0.25 to 0.7) | 0.001 |
 ED occupancy rate (+10%)b | 0.90 (0.85 to 0.96) | 0.001 |